글로벌 연구동향
분자영상 및 방사화학
- 2019년 08월호[Theranostics] Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry
서울대 / 박지용, 송명근, 김우형, 이윤상*, 강건욱*, 임형준*2019댓글: 0조회수: 1597
- 2019년 08월호[Bioconjug Chem.] PLGA Microspheres Coated with Cancer Cell-Derived Vesicles for Improved Internalization into Antigen-Presenting Cells and Immune Stimulation.
건국대 / 정혜선, 목혜정*2019 Jun 19댓글: 0조회수: 996
- 2019년 08월호[Bioconjug Chem.] Development of Theragnostic Tool Using NIR Fluorescence Probe Targeting Mitochondria in Glioma Cells.
신경 교종 세포의 미토콘드리아 표적 테라노스틱 근적외선 형광 프로브 개발아주대, KIST / 추연정, 김은하*, 이상희*2019 Jun 19댓글: 0조회수: 1467
- 2019년 06월호[Int J Mol Sci.] Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials.
경북대 / 전종호*2019 May 10댓글: 0조회수: 1062
- 2019년 06월호[Mol Pharm.] Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
Purdue University / 박진호, 여윤*2019 May 6댓글: 1조회수: 1027
- 2019년 06월호[J Control Release.] Hierarchical tumor acidity-responsive self-assembled magnetic nanotheranostics for bimodal bioimaging and photodynamic therapy.
바이오이미징 과 광역학치료을 위한 산도 반응성 자기조립 나노입자성균관대 / Hong Yu Yang, 이정희*, 이두성*2019 May 10댓글: 0조회수: 1121
- 2019년 06월호[J Med Chem.] Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib.
University of Kentucky / 이민재, 김경보*2019 May 9댓글: 0조회수: 1052
- 2019년 05월호[Clin Cancer Res.] A novel orally active inverse agonist of estrogen-related receptor gamma (ERRγ), DN200434, a booster of NIS in anaplastic thyroid cancer.
대구경북첨단의료산업진흥재단/ Thoudam Debraj Singh, 전용현*2019 Apr 22. pii: clincanres.3007.2018. doi: 10.11댓글: 0조회수: 1020
- 2019년 05월호[J Control Release.] Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy.
KIST / 조홍준, 김세훈*2019 Apr 28댓글: 1조회수: 1037
- 2019년 05월호[Theranostics] Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer
고려대 / 박성희, 오상철*, 이대희*2019댓글: 0조회수: 1119